Exosomal cell-to-cell transmission of alpha synuclein oligomers

Karin M. Danzer, Lisa R. Kranich, Wolfgang P. Ruf, Ozge Cagsal-Getkin, Ashley R. Winslow, Liya Zhu, Charles R. Vanderburg, Pamela J McLean

Research output: Contribution to journalArticle

354 Citations (Scopus)

Abstract

Background: Aggregation of alpha-synuclein (syn) and resulting cytotoxicity is a hallmark of sporadic and familial Parkinsons disease (PD) as well as dementia with Lewy bodies, with recent evidence implicating oligomeric and pre-fibrillar forms of syn as the pathogenic species. Recent in vitro studies support the idea of transcellular spread of extracellular, secreted syn across membranes. The aim of this study is to characterize the transcellular spread of syn oligomers and determine their extracellular location. Results: Using a novel protein fragment complementation assay where syn is fused to non-bioluminescent amino-or carboxy-terminus fragments of humanized Gaussia Luciferase we demonstrate here that syn oligomers can be found in at least two extracellular fractions: either associated with exosomes or free. Exosome-associated syn oligomers are more likely to be taken up by recipient cells and can induce more toxicity compared to free syn oligomers. Specifically, we determine that syn oligomers are present on both the outside as well as inside of exosomes. Notably, the pathway of secretion of syn oligomers is strongly influenced by autophagic activity. Conclusions: Our data suggest that syn may be secreted via different secretory pathways. We hypothesize that exosome-mediated release of syn oligomers is a mechanism whereby cells clear toxic syn oligomers when autophagic mechanisms fail to be sufficient. Preventing the early events in syn exosomal release and uptake by inducing autophagy may be a novel approach to halt disease spreading in PD and other synucleinopathies.

Original languageEnglish (US)
Article number42
JournalMolecular Neurodegeneration
Volume7
Issue number1
DOIs
StatePublished - 2012

Fingerprint

Synucleins
alpha-Synuclein
Exosomes
Secretory Pathway
Parkinson Disease
Lewy Body Disease
Poisons
Autophagy
Luciferases

Keywords

  • Aggregation
  • Alpha synuclein
  • Exosomes
  • Oligomers
  • Parkinsons disease
  • Secretion

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Clinical Neurology
  • Molecular Biology

Cite this

Danzer, K. M., Kranich, L. R., Ruf, W. P., Cagsal-Getkin, O., Winslow, A. R., Zhu, L., ... McLean, P. J. (2012). Exosomal cell-to-cell transmission of alpha synuclein oligomers. Molecular Neurodegeneration, 7(1), [42]. https://doi.org/10.1186/1750-1326-7-42

Exosomal cell-to-cell transmission of alpha synuclein oligomers. / Danzer, Karin M.; Kranich, Lisa R.; Ruf, Wolfgang P.; Cagsal-Getkin, Ozge; Winslow, Ashley R.; Zhu, Liya; Vanderburg, Charles R.; McLean, Pamela J.

In: Molecular Neurodegeneration, Vol. 7, No. 1, 42, 2012.

Research output: Contribution to journalArticle

Danzer, KM, Kranich, LR, Ruf, WP, Cagsal-Getkin, O, Winslow, AR, Zhu, L, Vanderburg, CR & McLean, PJ 2012, 'Exosomal cell-to-cell transmission of alpha synuclein oligomers', Molecular Neurodegeneration, vol. 7, no. 1, 42. https://doi.org/10.1186/1750-1326-7-42
Danzer KM, Kranich LR, Ruf WP, Cagsal-Getkin O, Winslow AR, Zhu L et al. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Molecular Neurodegeneration. 2012;7(1). 42. https://doi.org/10.1186/1750-1326-7-42
Danzer, Karin M. ; Kranich, Lisa R. ; Ruf, Wolfgang P. ; Cagsal-Getkin, Ozge ; Winslow, Ashley R. ; Zhu, Liya ; Vanderburg, Charles R. ; McLean, Pamela J. / Exosomal cell-to-cell transmission of alpha synuclein oligomers. In: Molecular Neurodegeneration. 2012 ; Vol. 7, No. 1.
@article{ecfee146b6ca4032bab889980d89b87c,
title = "Exosomal cell-to-cell transmission of alpha synuclein oligomers",
abstract = "Background: Aggregation of alpha-synuclein (syn) and resulting cytotoxicity is a hallmark of sporadic and familial Parkinsons disease (PD) as well as dementia with Lewy bodies, with recent evidence implicating oligomeric and pre-fibrillar forms of syn as the pathogenic species. Recent in vitro studies support the idea of transcellular spread of extracellular, secreted syn across membranes. The aim of this study is to characterize the transcellular spread of syn oligomers and determine their extracellular location. Results: Using a novel protein fragment complementation assay where syn is fused to non-bioluminescent amino-or carboxy-terminus fragments of humanized Gaussia Luciferase we demonstrate here that syn oligomers can be found in at least two extracellular fractions: either associated with exosomes or free. Exosome-associated syn oligomers are more likely to be taken up by recipient cells and can induce more toxicity compared to free syn oligomers. Specifically, we determine that syn oligomers are present on both the outside as well as inside of exosomes. Notably, the pathway of secretion of syn oligomers is strongly influenced by autophagic activity. Conclusions: Our data suggest that syn may be secreted via different secretory pathways. We hypothesize that exosome-mediated release of syn oligomers is a mechanism whereby cells clear toxic syn oligomers when autophagic mechanisms fail to be sufficient. Preventing the early events in syn exosomal release and uptake by inducing autophagy may be a novel approach to halt disease spreading in PD and other synucleinopathies.",
keywords = "Aggregation, Alpha synuclein, Exosomes, Oligomers, Parkinsons disease, Secretion",
author = "Danzer, {Karin M.} and Kranich, {Lisa R.} and Ruf, {Wolfgang P.} and Ozge Cagsal-Getkin and Winslow, {Ashley R.} and Liya Zhu and Vanderburg, {Charles R.} and McLean, {Pamela J}",
year = "2012",
doi = "10.1186/1750-1326-7-42",
language = "English (US)",
volume = "7",
journal = "Molecular Neurodegeneration",
issn = "1750-1326",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Exosomal cell-to-cell transmission of alpha synuclein oligomers

AU - Danzer, Karin M.

AU - Kranich, Lisa R.

AU - Ruf, Wolfgang P.

AU - Cagsal-Getkin, Ozge

AU - Winslow, Ashley R.

AU - Zhu, Liya

AU - Vanderburg, Charles R.

AU - McLean, Pamela J

PY - 2012

Y1 - 2012

N2 - Background: Aggregation of alpha-synuclein (syn) and resulting cytotoxicity is a hallmark of sporadic and familial Parkinsons disease (PD) as well as dementia with Lewy bodies, with recent evidence implicating oligomeric and pre-fibrillar forms of syn as the pathogenic species. Recent in vitro studies support the idea of transcellular spread of extracellular, secreted syn across membranes. The aim of this study is to characterize the transcellular spread of syn oligomers and determine their extracellular location. Results: Using a novel protein fragment complementation assay where syn is fused to non-bioluminescent amino-or carboxy-terminus fragments of humanized Gaussia Luciferase we demonstrate here that syn oligomers can be found in at least two extracellular fractions: either associated with exosomes or free. Exosome-associated syn oligomers are more likely to be taken up by recipient cells and can induce more toxicity compared to free syn oligomers. Specifically, we determine that syn oligomers are present on both the outside as well as inside of exosomes. Notably, the pathway of secretion of syn oligomers is strongly influenced by autophagic activity. Conclusions: Our data suggest that syn may be secreted via different secretory pathways. We hypothesize that exosome-mediated release of syn oligomers is a mechanism whereby cells clear toxic syn oligomers when autophagic mechanisms fail to be sufficient. Preventing the early events in syn exosomal release and uptake by inducing autophagy may be a novel approach to halt disease spreading in PD and other synucleinopathies.

AB - Background: Aggregation of alpha-synuclein (syn) and resulting cytotoxicity is a hallmark of sporadic and familial Parkinsons disease (PD) as well as dementia with Lewy bodies, with recent evidence implicating oligomeric and pre-fibrillar forms of syn as the pathogenic species. Recent in vitro studies support the idea of transcellular spread of extracellular, secreted syn across membranes. The aim of this study is to characterize the transcellular spread of syn oligomers and determine their extracellular location. Results: Using a novel protein fragment complementation assay where syn is fused to non-bioluminescent amino-or carboxy-terminus fragments of humanized Gaussia Luciferase we demonstrate here that syn oligomers can be found in at least two extracellular fractions: either associated with exosomes or free. Exosome-associated syn oligomers are more likely to be taken up by recipient cells and can induce more toxicity compared to free syn oligomers. Specifically, we determine that syn oligomers are present on both the outside as well as inside of exosomes. Notably, the pathway of secretion of syn oligomers is strongly influenced by autophagic activity. Conclusions: Our data suggest that syn may be secreted via different secretory pathways. We hypothesize that exosome-mediated release of syn oligomers is a mechanism whereby cells clear toxic syn oligomers when autophagic mechanisms fail to be sufficient. Preventing the early events in syn exosomal release and uptake by inducing autophagy may be a novel approach to halt disease spreading in PD and other synucleinopathies.

KW - Aggregation

KW - Alpha synuclein

KW - Exosomes

KW - Oligomers

KW - Parkinsons disease

KW - Secretion

UR - http://www.scopus.com/inward/record.url?scp=84865307818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865307818&partnerID=8YFLogxK

U2 - 10.1186/1750-1326-7-42

DO - 10.1186/1750-1326-7-42

M3 - Article

C2 - 22920859

AN - SCOPUS:84865307818

VL - 7

JO - Molecular Neurodegeneration

JF - Molecular Neurodegeneration

SN - 1750-1326

IS - 1

M1 - 42

ER -